1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
Bergquist, Filip ; Ehrnebo, Mats ; Nyholm, Dag ; Johansson, Anders ; Lundin, Fredrik ; Odin, Per LU
; Svenningsson, Per
; Dizdar, Nil
and Eriksson, Elias
(2024)
In Movement Disorders Clinical Practice
11(9).
p.1095-1102
- Contribution to journal › Article
- 2023
-
Mark
The Impact of COVID-19 on Parkinson's Disease : A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions
Cedergren Weber, Gustav LU ; Timpka, Jonathan LU ; Bergquist, Filip ; Bäckström, David ; Dizdar, Nil ; Gunnarsson, Karin ; Nyholm, Dag LU ; Svenningsson, Per and Odin, Per LU
(2023)
In Acta Neurologica Scandinavica
2023.
- Contribution to journal › Article
- 2022
-
Mark
Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
Bergquist, Filip ; Ehrnebo, Mats ; Nyholm, Dag ; Johansson, Anders ; Lundin, Fredrik ; Odin, Per LU
; Svenningsson, Per
; Hansson, Fredrik
; Bring, Leif
and Eriksson, Elias
, et al.
(2022)
In Neurology
99(10).
p.965-976
- Contribution to journal › Article
- 2020
-
Mark
Parkinsons sjukdom – heterogen och komplex i sitt kliniska uttryck - Individuella kombinationer av symtom som ändrar sig över tid kräver behandlingsjusteringar och anpassningar
Bergquist, Filip LU ; Johansson, Anders ; Dizdar, Nil ; Widner, Håkan LU ; Nyholm, Dag LU ; Odin, Per LU
and Svenningsson, Per
(2020)
In Läkartidningen
117.
- Contribution to journal › Article
-
Mark
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
Svenningsson, Per ; Odin, Per LU
; Dizdar, Nil
; Johansson, Anders
; Grigoriou, Sotirios
LU
; Tsitsi, Panagiota
; Wictorin, Klas
LU
; Bergquist, Filip
; Nyholm, Dag
LU
and Rinne, Juha
, et al.
(2020)
In Movement Disorders
35(6).
p.1046-1054
- Contribution to journal › Article
- 2018
-
Mark
Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease
Odin, Per LU
; Chaudhuri, K Ray
; Volkmann, Jens
; Antonini, Angelo
; Storch, Alexander
; Dietrichs, Espen
; Pirtošek, Zvezdan
; Henriksen, Tove
; Horne, Malcolm
and Devos, David
, et al.
(2018)
In npj Parkinson's Disease
4.
p.1-7
- Contribution to journal › Scientific review
- 2006
-
Mark
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: Effect of in vitro differentiation on graft survival and teratoma formation
Brederlau, Anke ; Correia, Ana Sofia ; Anisimov, Sergey LU ; Elmi, Muna ; Paul-Visse, Gesine LU
; Roybon, Laurent
LU
; Morizane, Asuka
; Bergquist, Filip
; Riebe, Ilse
and Nannmark, Ulf
, et al.
(2006)
In Stem Cells
24(6).
p.1433-1440
- Contribution to journal › Article